该公司主要从事骨科和脊柱生物学领域。它提供固定系统和生物学产品,旨在治疗脊柱和骨科疾病。
排他性优势:
1. 拥有强大的研发能力,能不断开发和推出创新产品,如新的固定系统和生物学产品。
2. 构建了一个互补的产品组合,包括固定和生物学解决方案,能...查看全文
$Xtant Medical Holdings, Inc.(XTNT)$ 10-Q/A [Amend] - Quarterly report [Sections 13 or 15(d)] Filed: 2018-03-30 AccNo: 0001144204-18-018329 Size: 5 MB 网页链接
$Xtant Medical Holdings, Inc.(XTNT)$ 10-Q/A [Amend] - Quarterly report [Sections 13 or 15(d)] Filed: 2018-03-30 AccNo: 0001144204-18-018327 Size: 4 MB 网页链接
$Xtant Medical Holdings, Inc.(XTNT)$ 8-K - Current report Filed: 2018-03-27 AccNo: 0001144204-18-017015 Size: 37 KBItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接
$Xtant Medical Holdings, Inc.(XTNT)$ 内部交易: 2018-02-14,Director,Eggenberg Michael ,买入,945819普通股, $7.20
$Xtant Medical Holdings, Inc.(XTNT)$ 内部交易: 2018-02-14,Director,Rizzo Matthew ,买入,945819普通股, $7.20
$Xtant Medical Holdings, Inc.(XTNT)$ 内部交易: 2018-02-14,Director,ORBIMED ADVISORS LLC ,买入,945819普通股, $7.20
$Xtant Medical Holdings, Inc.(XTNT)$ 8-K - Current report Filed: 2018-02-16 AccNo: 0001144204-18-009541 Size: 457 KBItem 1.01: Entry into a Material Definitive AgreementItem 1.02: Termination of a Material Definitive AgreementItem 2.03: Creation of a Direct Financial Obligati...
$Xtant Medical Holdings, Inc.(XTNT)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2018-02-15 AccNo: 0000947871-18-000155 Size: 149 KB 网页链接
$Xtant Medical Holdings, Inc.(XTNT)$ 8-K - Current report Filed: 2018-02-15 AccNo: 0001144204-18-009155 Size: 27 KBItem 8.01: Other Events 网页链接
$Xtant Medical Holdings, Inc.(XTNT)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2018-02-14 AccNo: 0000905718-18-000246 Size: 91 KB 网页链接